Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 4:2020:8889061.
doi: 10.1155/2020/8889061. eCollection 2020.

Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?

Affiliations
Review

Stem Cell Therapy for Neurodegenerative Diseases: How Do Stem Cells Bypass the Blood-Brain Barrier and Home to the Brain?

Yvonne Cashinn Chia et al. Stem Cells Int. .

Abstract

Blood-brain barrier (BBB) is a term describing the highly selective barrier formed by the endothelial cells (ECs) of the central nervous system (CNS) homeostasis by restricting movement across the BBB. An intact BBB is critical for normal brain functions as it maintains brain homeostasis, modulates immune cell transport, and provides protection against pathogens and other foreign substances. However, it also prevents drugs from entering the CNS to treat neurodegenerative diseases. Stem cells, on the other hand, have been reported to bypass the BBB and successfully home to their target in the brain and initiate repair, making them a promising approach in cellular therapy, especially those related to neurodegenerative disease. This review article discusses the mechanism behind the successful homing of stem cells to the brain, their potential role as a drug delivery vehicle, and their applications in neurodegenerative diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The multistep cascade of MSC homing mechanism consists of five different steps, namely, (1) tethering and rolling, (2) activation by cytokines, (3) cell arrest by integrins, (4) transmigration, and (5) migration.

References

    1. Daneman R., Prat A. The blood–brain barrier. Cold Spring Harbor Perspectives in Biology. 2015;7(1, article a020412) doi: 10.1101/cshperspect.a020412. - DOI - PMC - PubMed
    1. Warren K. E. Beyond the blood:brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine glioma. Frontiers in Oncology. 2018;8:p. 239. doi: 10.3389/fonc.2018.00239. - DOI - PMC - PubMed
    1. Abbott N. J. Astrocyte-endothelial interactions and blood-brain barrier permeability. Journal of Anatomy. 2002;200(6):629–638. doi: 10.1046/j.1469-7580.2002.00064.x. - DOI - PMC - PubMed
    1. Ballabh P., Braun A., Nedergaard M. The blood–brain barrier: an overview. Neurobiology of Disease. 2004;16(1):1–13. doi: 10.1016/j.nbd.2003.12.016. - DOI - PubMed
    1. Banks W. A. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery. Nature Reviews Drug Discovery. 2016;15(4):275–292. doi: 10.1038/nrd.2015.21. - DOI - PubMed

LinkOut - more resources